Sign inJoin waitlistJoin the waitlist

Steven Rosenberg

, Chief of the · Clinical Center at the National Institutes of Health

Credentials: · · ·

History

the Division · Clinical Center at the National Institutes of Health
Present
Tumor Immunology Section Division · Clinical Center at the National Institutes of Health
Present

Hematology and Medical Oncology
Clinical Center at the National Institutes of Health
2015–2018
Internal Medicine
2015–2018
Hopkins University in Baltimore
George Washington University School of Medicine
2011–2015
The Johns Hopkins University

Research

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone
New England Journal of Medicine · 1987 · First of over 10 authors · 2,870 citations
Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer
New England Journal of Medicine · 1985 · First of over 10 authors · 2,521 citations
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
The Lancet · 2015 · 2,436 citations

James Yang
129 papers
Suzanne Topalian
68 papers
JW
John Wunderlich
66 papers
Stephanie Goff
56 papers · 13 as a resident
FM
Francesco Marincola
55 papers
Udai Kammula
54 papers · 10 as a resident
Michael Lotze
48 papers
Patrick Hwu
40 papers · 6 as a fellow
DS
Douglas Schwartzentruber
37 papers
Marybeth Hughes
32 papers · 5 as a fellow
James Kochenderfer
26 papers
Christian Hinrichs
23 papers · 8 as a fellow

Grants

Gene Therapy of Cancer
National Cancer Institute · ZIA
Contact PI · $56.8M · Division of Basic Sciences - Nci
Adoptive Cell Transfer Immunotherapy of Cancer
National Cancer Institute · ZIA
Contact PI · $56.8M · Division of Basic Sciences - Nci
Surgical Consultants Collaborative Research Involving Surgical Services at NIH
National Cancer Institute · ZID
Contact PI · $34.5M · Division of Clinical Sciences - Nci
Surgical Consultants & Collaborative Research Involving Surgical Services at NIH
National Cancer Institute · Z01
Contact PI · $7.5M · Division of Clinical Sciences - Nci

Clinical trials

Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer
Principal investigator · Active not recruiting · Phase 1
National Cancer Institute (NCI)
2024–2029
Non-Viral TCR Gene Therapy
Principal investigator · Withdrawn · Phase 2
National Cancer Institute (NCI)
2024
Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment
Principal investigator · Enrolling by invitation
National Cancer Institute (NCI)
2023–2033
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Mutated or Viral Neoantigens in a Patient With Metastatic Cancer Plus the Administration of Pembrolizumab
Principal investigator · Withdrawn · Phase 2
National Cancer Institute (NCI)
2021